Thank you for visiting Gilead.com. Please explore this section for the latest news about Gilead, our groundbreaking research and our therapeutics.

Please see Gilead-at-a-Glance to learn more about the company and our portfolio of products.

Sign-up to receive email alerts whenever new company information is posted to the site.

Recent News

November 14, 2008
Gilead Sciences Announces Notification of ANDA Filing for Truvada

November 5, 2008
Gilead Sciences to Present at Three Upcoming Investor Conferences

November 1, 2008
Gilead Announces Two-Year Data from Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B

October 30, 2008
Gilead Sciences to Present at the Oppenheimer 19th Annual Healthcare Conference on Tuesday, November 4

October 28, 2008
Gilead Announces Two-Year Clinical Data for Letairis(R) (ambrisentan) for the Treatment of Pulmonary Arterial Hypertension (WHO Group 1)

October 23, 2008
Gilead Signs Agreement with EFI to Acquire Building and Associated Land Bordering Gilead's Foster City Campus

October 16, 2008
Gilead Sciences Announces Third Quarter 2008 Financial Results

October 9, 2008
Gilead Sciences to Release Third Quarter 2008 Financial Results on Thursday, October 16, 2008